These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19225762)
1. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Meyer PJ; Morgan MM; Kozell LB; Ingram SL Psychopharmacology (Berl); 2009 Jun; 204(3):531-40. PubMed ID: 19225762 [TBL] [Abstract][Full Text] [Related]
2. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats. Schoo SM; Bobeck EN; Morgan MM Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893 [TBL] [Abstract][Full Text] [Related]
3. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Morgan MM; Bobeck EN; Ingram SL Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608 [TBL] [Abstract][Full Text] [Related]
4. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat. Campion KN; Saville KA; Morgan MM Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986 [TBL] [Abstract][Full Text] [Related]
5. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance. Morgan MM; Clayton CC; Lane DA Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152 [TBL] [Abstract][Full Text] [Related]
6. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. Wilson-Poe AR; Lau BK; Vaughan CW Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363 [TBL] [Abstract][Full Text] [Related]
7. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats. Lane DA; Patel PA; Morgan MM Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660 [TBL] [Abstract][Full Text] [Related]
8. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats. Tortorici V; Nogueira L; Salas R; Vanegas H Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592 [TBL] [Abstract][Full Text] [Related]
9. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray. Morgan MM; Tran A; Wescom RL; Bobeck EN Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128 [TBL] [Abstract][Full Text] [Related]
10. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Flores JA; El Banoua F; Galán-Rodríguez B; Fernandez-Espejo E Pain; 2004 Jul; 110(1-2):205-14. PubMed ID: 15275769 [TBL] [Abstract][Full Text] [Related]
11. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits. Williams FG; Mullet MA; Beitz AJ Brain Res; 1995 Sep; 690(2):207-16. PubMed ID: 8535838 [TBL] [Abstract][Full Text] [Related]
12. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the periaqueductal gray in the effect of motor cortex stimulation. Chiou RJ; Chang CW; Kuo CC Brain Res; 2013 Mar; 1500():28-35. PubMed ID: 23337618 [TBL] [Abstract][Full Text] [Related]
14. Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain. Li C; Sugam JA; Lowery-Gionta EG; McElligott ZA; McCall NM; Lopez AJ; McKlveen JM; Pleil KE; Kash TL Neuropsychopharmacology; 2016 Jul; 41(8):2122-32. PubMed ID: 26792442 [TBL] [Abstract][Full Text] [Related]
15. Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons. Tortorici V; Morgan MM J Neurophysiol; 2002 Oct; 88(4):1707-15. PubMed ID: 12364500 [TBL] [Abstract][Full Text] [Related]
16. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception. Wilson AR; Maher L; Morgan MM Neuropharmacology; 2008 Dec; 55(7):1219-25. PubMed ID: 18723035 [TBL] [Abstract][Full Text] [Related]
17. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats. Pavlovic ZW; Cooper ML; Bodnar RJ Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699 [TBL] [Abstract][Full Text] [Related]
18. Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray. Robertson JA; Bodnar RJ Pain; 1993 Oct; 55(1):71-84. PubMed ID: 8278212 [TBL] [Abstract][Full Text] [Related]
19. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats. Tortorici V; Morgan MM; Vanegas H Pain; 2001 Jan; 89(2-3):237-44. PubMed ID: 11166480 [TBL] [Abstract][Full Text] [Related]
20. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]